ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OPTI Optibiotix Health Plc

17.75
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 17.75 17.50 18.00 17.75 17.75 17.75 58,159 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 6.25 16.19M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 17.75p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £16.19 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 6.25.

Optibiotix Health Share Discussion Threads

Showing 37751 to 37772 of 147550 messages
Chat Pages: Latest  1522  1521  1520  1519  1518  1517  1516  1515  1514  1513  1512  1511  Older
DateSubjectAuthorDiscuss
23/5/2018
08:08
As we have said multiple times from SOH, you are not going to get forecast until he can give an accurate forecast. People expected too much as I said yesterday!
primal123
23/5/2018
08:07
No placing for Opti but is SOH hinting at another listing in the future like SBTX?
m4rtinu
23/5/2018
08:06
Nice to get the truth from those that went to the annual general meeting. Lots of long term holders who know exactly what is going on...
bobdown2
23/5/2018
08:05
Guys as Investors we have to take balanced views. The positives are all the deals, awards, recognition, product development. The negatives are lack of evidence of products on shelves, subsequent lack of revenue, increased burn. It will shake out the weak holders and leave opportunity for Insti's and believers. I agree with Rathean above and the half year results in August need to, as an old boss used to say to me "put it in my hand"
malreid
23/5/2018
08:05
As i said yesterday, highly predictable. Revenue forecast needed.

Technically needs to hold in the high 60s as move higher over the coming weeks. share price is still not out of the multi year downtrend.

john henry
23/5/2018
08:01
Appalling results.No substance.Worthless agreements.No real business...
vanduke
23/5/2018
07:59
Lucky they have 11m in SBTX if required then ;0) NO PLACING - SoH Said as much at UKI
trotterstrading
23/5/2018
07:59
More confetti needed
hamidahamida
23/5/2018
07:58
So much BS in the results.Very selective 're information.Mis-information continues
vanduke
23/5/2018
07:58
Roll - SOH has confirmed break even this year, big deals have been made since Nov 17. There will be increased revenues since Nov 17.
primal123
23/5/2018
07:58
If they have received much higher revenues since 1st Dec 2017, why not update the market with the numbers?
pugg1ey
23/5/2018
07:55
@Primal - re: placing indeed he has stated that but the accounts do not lie.. unless they've received significantly higher revenues since 30th Nov, at current cash burn rates they will need money whether from debt, equity or contracts being monetised.
rollthedice
23/5/2018
07:54
44p soon..True value £25 million at best...
vanduke
23/5/2018
07:48
During numerous interviews SOH has stated they are looking to break even this year, so there will be no need for a placement. Excellent progress has been made over the past 18 months, and the next 12 are going to be even more exciting. As SOH states:We look forward to converting this interest into a GROWING number of revenue generating deals, of INCREASING value and in a WIDER range of territories.
parob
23/5/2018
07:46
There is no doubt that their product is widely received as market leading and the next big thing, the science is proven and the names signed up already are huge.But, no revenue to speak of because they are still transitioning, increasing costs and a statement about needing to restructure the management group suggest to me that current valuation is optimistic.12-18 months from now this will be a no-brainer but imho until they turn potential into the bottom line then the 2 year trading range will continue for a while longer.
rathean
23/5/2018
07:46
Rollthedice - how many times do people need confirmation that a placing will NOT happen! Confirmed by SOH!
primal123
23/5/2018
07:42
Big drop today IMO.Multiple deals across multiple products..No revenues...No cash...No business..
vanduke
23/5/2018
07:40
No revenues...Dwindling cash..Placing imminent...Multiple deals with no actual revenues...Not a valid business model...
vanduke
23/5/2018
07:26
Results out ~ operating loss of £2.13m but after the SBTX non-cash adjustment profit of £1.69m reported. All coming together but cash at £1.25m at 30Nov and little reported revenues in/after period would suggest to me that a placing could be on the cards.

Happy to hold but won't add until after (any) placing.

rollthedice
22/5/2018
22:58
I have a feeling we may get Sweetbiotix news tomorrow, maybe the appointment of the new lead?
trotterstrading
22/5/2018
22:40
Glad the board is starting to understand how the market works. Well done all.
monkeywench1
22/5/2018
22:34
Frequency of the deals isn't so important without a yardstick to measure the revenues each are worth. Until then no insti will bite without a favourable placing for them to get the size they want.
slartybartfaster
Chat Pages: Latest  1522  1521  1520  1519  1518  1517  1516  1515  1514  1513  1512  1511  Older

Your Recent History

Delayed Upgrade Clock